CHINA approved a value-added tax (VAT) law on Wednesday (Dec 25) to take effect on Jan 1, 2026, the official Xinhua said, bringing into one document previous regulations that have included exempting ...

Trump had demanded. Carl Hulse Maya C. Miller and Catie Edmondson The Senate approved legislation to avert a federal government shutdown just after a midnight deadline, capping a chaotic week in ...

Capital markets regulator Sebi on Wednesday approved a series of measures in order to strengthen the SME IPO market, improve the quality of listings and protect investors' interest. These new rules ...

ISLAMABAD: Based on a few datasets, the government claimed the effectiveness of its policies towards macroeconomic stability on Wednesday and approved about Rs 44 billion in supplementary grants ...

History is made as the FDA approves Mesoblast’s Ryoncil for paediatric graft-versus-host disease LTR Pharma firms up a compact with the Mens Health Downunder network The paperwork’s in! Orthocell ...

A picture of the crowd at the Fort Smith City Board meeting on Tuesday, Dec. 17. Credit: Jo Elsken Fort Smith’s City Board of Directors voted to move forward with implementing a $14.5 million ...

The Food and Drug Administration (FDA) announced in a statement Tuesday that it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides ...

The Biden administration on Wednesday approved California’s trailblazing rules that would set stricter-than-federal emissions standards, in a bid to ban gas car sales by 2035. In doing so ...

This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease. The Food and Drug Administration (FDA) approved Ryoncil (remestemcel-L-rknd ...

However, the FDA noted in its approval announcement that there was no statistically significant difference regarding overall survival. The most common side effects experienced by at least 20% of ...

The US Food and Drug Administration (FDA) has approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for the treatment of adults with ALK-positive locally advanced or metastatic non-small cell ...